Home » Ablynx Initiates Phase II Clinical Trial
Ablynx Initiates Phase II Clinical Trial
Ablynx Thursday announced that it has opened recruitment in its first clinical trial center for an open-label, randomized Phase II study for patients with acquired thrombotic thrombocytopenic purpura.
Euroinvestor
Euroinvestor
Upcoming Events
-
07May
-
14May
-
30May